EFFECT OF IMMUNOTHERAPY ACTIVATED T-LYMPHOCYTES ON CELLULAR IMMUNITY IN DIFFERENT FORMS OF ATOPIC DERMATITIS
Abstract
The article describes the results of therapy with autologous activated. T-lymphocytes in patients with atopic dermatitis. Has been shown high clinical efficacy and safety of this therapy in the treatment of patients with both allergic and nonallergic form of the disease. In the allergic form observed more rapid positive changes, but in the opposite form of the efficiency was higher. Influence on cellular immunity in different forms differed. If the allergic form there was an increase of CD8+ T-cells in the nonallergic form — increased CD8+CD25+ T-cells and changes in delayed-type hypersensitivity.
About the Authors
N. A. Shestakova
Research Institute of Medical Problems of the North SB RAMS
Russian Federation
Russian Federation
V. S. Kozhevnikov
Research Institute of Clinical Immunology SB RAMS
Russian Federation
Russian Federation
References
1. Кожевников В.С., Баровская Н.А., Королькова О.Ю., Непомнящих В.М. и др. Способ лечения атопического дерматита: пат. 2340348 Рос. Федерация // патентообладатель ГУ НИИ клинической иммунологии СО РАМН. - заявл. 04.04.2007; опубл. 610.12.2008. - Бюл. 34. - 1 с.
2. Лозовой В.П., Кожевников В.С. Методы оценки клеточных эффекторных функций гиперчувствительности замедленного типа: метод. рек. МЗ СССР. - М., 1990. - 11 с.
3. Bienvenu B., Martin B., Auffray C., Cordier C. et al. Peripheral CD8 + CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity // J. Immunol. - 2005. - Vol. 175. -P. 246-253.
4. Cohen I.R., Quintana F.J., Mimran A. Tregs in T cell vaccination: exploring the regulation of regulation // J. Clin. Invest. - 2004. - Vol. 114. -P. 1227-1232.
5. Correale J., Rojany M., Weiner L.P. Human CD8+ TCRa/b+ and TCRg/d+ cells modulate autologous autoreactive neuroantigen-specific CD4 + T-cells by different mechanisms // J. Neuroimmu-nol. - 1997. - Vol. 80. - P. 47-64.
6. Cosmi L., Liotta F., Lazzeri E., Francalanci M. et al. Human CD8 + CD25 + thymocytes sharing phenotypic and functional features with CD4 + CD25+ regulatory thymocytes // Blood. - 2003. - Vol. 102. -P. 4107-4114.
7. Huurman V.A., Decochez K., Mathieu C., Cohen I.R. et al. Therapy with the hsp60 peptide DiaPep277 in C-peptide positive type 1 diabetes patients // Diabetes Metab. Res. Rev. - 2007. -Vol. 23(4). - P. 269-275.
8. Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I. et al. New insights into atopic dermatitis // J. Clin. Invest. - 2004. - Vol. 113 (5). -P. 651 -657.
9. Ling E.M., Smith T., Nguyen X.D., Pridgein C. et al. Relation of CD4 + CD25 + regulatory T-cell suppression of allergen-driven T-cell activation in atopic status and expression of allergic disease // Lancet. - 2004. - Vol. 363. - P. 608-615.
10. Lohse A.W., Mor F., Karin N., Cohen I.R. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells // Science. -1989. - Vol. 244. - P. 820-822.
11. Mimran A., Mor F., Carmi P., Quintana F.J. et al. DNA vaccination with CD25 protects rats from adjuvant arthritis and induces an antiergotypic response // J. Clin. Invest. - 2004. - Vol. 113. - P. 924-932.
12. Novak N., Bieber T., Leung D.Y.M. Immune mechanisms leading to atopic dermatitis // J. Allergy Clin. Immunol. - 2003. - Vol. 112. -P. 128- 139.
13. Robinson D.S., Larché M., Durham R. Treg and allergic disease // J. Clin. Invest. - 2004. -Vol. 114 (10). - P. 1389-1397.
14. Shi H.-Z., Qin X.-J. CD4 + CD25+ regulatory T lymphocytes in allergy and asthma // Allergy. - 2005. - Vol. 60. - P. 986-995.
15. Zang Y.C., Hong J., Rivera V.M., Killian J. et al. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination // J. Immunol. - 2000. - Vol. 164. -P. 4011-4017.
Review
For citations:
Shestakova N.A., Kozhevnikov V.S. EFFECT OF IMMUNOTHERAPY ACTIVATED T-LYMPHOCYTES ON CELLULAR IMMUNITY IN DIFFERENT FORMS OF ATOPIC DERMATITIS. Acta Biomedica Scientifica. 2012;(3(2)):226-230. (In Russ.)
Views:
386
Email this article 
